Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Genelux Corp. (GNLX) vs. Competitors

305 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GNLXGenelux Corp.$2.24$96.13M-2.16-55.73%Moderate BuyUnlock the GNLX analyst price target with TipRanks PremiumGNLXUnlock the GNLX top-analyst price target with TipRanks Premium
CHRSCoherus Biosciences$0.41$73.95M-0.45-66.20%Strong BuyUnlock the CHRS analyst price target with TipRanks PremiumGNLX vs CHRSUnlock the CHRS top-analyst price target with TipRanks Premium
FATEFate Therapeutics$1.05$124.00M-0.992.94%Moderate BuyUnlock the FATE analyst price target with TipRanks PremiumGNLX vs FATEUnlock the FATE top-analyst price target with TipRanks Premium
TNXPTonix Pharma$2.82$57.13M-0.24-82.71%Strong BuyUnlock the TNXP analyst price target with TipRanks PremiumGNLX vs TNXPUnlock the TNXP top-analyst price target with TipRanks Premium
CRBPCorbus Pharmaceuticals$2.75$62.03M-0.47-77.14%Strong BuyUnlock the CRBP analyst price target with TipRanks PremiumGNLX vs CRBPUnlock the CRBP top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GNLXGenelux Corp.2.24-2.76-55.20%
CHRSCoherus Biosciences0.41-0.75-64.74%
FATEFate Therapeutics1.050.000.00%
TNXPTonix Pharma2.82-13.90-83.13%
CRBPCorbus Pharmaceuticals2.75-9.07-76.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts